Tackling the overdose crisis: The role of safe supply
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
North America is experiencing an unprecedented overdose crisis driven by the proliferation of fentanyl and its analogues in the illicit drug supply. In 2018 there were 67,367 drug overdose deaths in the United States, and since 2016, there have been more than 14,700 overdose deaths in Canada, with most related to fentanyl. Despite concerted efforts and some positive progress, current public health, substance use treatment, and harm reduction interventions (such as widespread naloxone distribution and implementation of supervised consumption sites) have not been able to rapidly decrease overdose fatalities. In view of the persistent gaps in services and the limitations of available options, immediate scale-up of low-barrier opioid distribution programs are urgently needed. This includes “off-label” prescription of pharmaceutical grade opioids (e.g., hydromorphone) to disrupt the toxic drug supply and make safer opioids widely available to people at high risk of fatal overdose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opioid crisis: no easy fix to its social and economic determinants
Dasgupta, N., Beletsky, L., & Ciccarone, D. (2018) · American Journal of Public Health · doi:10.2105/ajph.2017.304187 · Cited by 923
Self-citationDegenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., & McLaren, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03140.x · Cited by 856
National and state treatment need and capacity for opioid agonist medication-assisted treatment
Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302664 · Cited by 668
Management of opioid use disorder in the USA: present status and future directions
Blanco, C., & Volkow, N. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33078-2 · Cited by 407
Karamouzian, M., Dohoo, C., Forsting, S., McNeil, R., Kerr, T., & Lysyshyn, M. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0252-8 · Cited by 209 · cited 1×
“Harm reduction strategies (e.g., naloxone distribution, low-barrier supervised consumption service, drug checking technologies) have rapidly expanded in Canada in efforts to curb overdose fatalities (Fairbairn, Coffin & Walley, 2017; Karamouzian et al., 2018; Wallace, Pagan & Pauly, 2019).”
BackgroundSelf-citation
Cited by
Humphreys, K., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cuéllar, M.-F., Hurd, Y. L., Juurlink, D. N., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02252-2 · Cited by 421
Imtiaz, S., Nafeh, F., Russell, C., Ali, F., Elton-Marshall, T., & Rehm, J. (2021) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/s13011-021-00423-5 · Cited by 101
“Criminalization Causes the Stigma”: Perspectives From People Who Use Drugs
Scher, B. D., Neufeld, S. D., Butler, A., Bonn, M., Zakimi, N., Farrell, J., & Greer, A. (2023) · Contemporary Drug Problems · doi:10.1177/00914509231179226 · Cited by 90
“Despite these innovations, in recent years, academic, public health, community activist groups, and even some branches of law enforcement (Canadian Association of Police Chiefs, 2020; Zimonjic, 2020), have called for more robust policy reform such as the decriminalization of illegal drugs and the implementation of wid…”
BackgroundPark, J. N., Sherman, S. G., Sigmund, V., Breaud, A., Martin, K., & Clarke, W. A. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109610 · Cited by 43
Gomes, T., Kitchen, S. A., Tailor, L., Men, S., Murray, R., Bayoumi, A. M., Campbell, T., Young, S., & Kolla, G. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000928 · Cited by 36
Metadata
- Authors
- Ivsins, A., Boyd, J., Beletsky, L., & McNeil, R.
- Venue
- International Journal of Drug Policy
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 80
- Pages
- 102769
- ISSN
- 0955-3959 (ISSN-L)
- OpenAlex
- W3021173945
- Cited by
- 212
- References
- 5
- FWCI
- 22.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tackling the overdose crisis: The role of safe supply. https://app.cochat.ai/papers/10.1016/j.drugpo.2020.102769
- The paper
- Ivsins, A., Boyd, J., Beletsky, L., & McNeil, R. (2020). Tackling the overdose crisis: The role of safe supply. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2020.102769
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.